The infection control solution

Rhonda player with two new disks: MRSA and Respi


Safe. Simple. Efficient.

Test with Rhonda for infectious diseases at the point of care, i.e. at hospital admission. Decide on the spot: isolate or not.


The challenge

Infectious diseases

With epidemic and pandemic infectious diseases like COVID-19, increased testing capacities are critical for infection control. Since the virus is novel, there is no immunity and no remedy yet.

Waiting for lab results

Following symptom onset and hospital admission, it takes long hours or even days of waiting for lab results to determine the need for patient quarantine.

Risk of infection

Manually handling samples increases the risk of infections for health care professionals analyzing them.

The point-of-care solution to control infectious diseases…

providing results for close to 60 patients per device right at the patient admission every day.

Seven days a week.


No manual handling of samples needed: Just use your standard swabs and directly insert them into the cartridge. For a better protection of the health care professionals who analyze them.


No sample prep, no pipetting, no additional reagents: from swab to decision in well under one hour. Decide on the spot: quarantine or not.


Increasing patient safety affordably while cutting costs at the same time. Sounds like a win-win to us.

Centrifugal microfluidic technology

Rhonda disk

Insert a standard COPAN eSwab® . Follow your usual routines.

Ultrafast and sensitive PCR for fast and reliable results.

Affordable even for screening applications.

Rhonda player with two new disks: MRSA and Respi

Rhonda player

Three buttons, no touch. Simple is back.

Two analyses for the same pathogens can be analyzed in one run.

One player for numerous applications. Introducing the Rhonda platform.

Rhonda is a registred trademark of Spindiag GmbH

“I think this system particularly makes sense in intermediate care wards. From my own experience, if a patient is admitted to the hospital and the history indicates previous MRSA or 4MRGN, it’s useful to know within half an hour whether I need to isolate the patient and initiate further steps.”

Katrin Reiser, Nurse, Large clinic and specialist clinic for cardiovascular diseases

“In my experience, the system is very useful and very helpful, especially with the functions I saw. It saves a lot of effort and time, in terms of days and beds – just what Spindiag designed it for. The system is a really good idea! I didn’t know this was technically possible. Awesome!”

Emil Benrath, Nurse, University Heart Center, ward for cardiac surgery

“Spindiag´s system makes a lot of sense. I witness it myself: In the hospital, two patients are kept together, and late in the process it turns out that one patient has a pathogen. With such a system, you could recognise much faster: You need to isolate the patient.”

Anonymous, Nurse, Center for Paediatrics and Youth Medicine, University Hospital

“The system is very useful! Since we receive many patients from external hospitals, we must isolate them on arrival. This costs a lot of time and money for everyone. In our case, it is meaningful to get the test result within half an hour.”

Florian Bechtel, Nurse, Public hospital, Intensive Care Unit

“This system makes a lot of sense and saves a lot of work, since you find out in only 30 minutes if the patient needs to be isolated or not!”

Dominik Scheffel, Nurse, District hospital Emmendingen, ward with focus on geriatric early rehabilitative complex treatment

“Die Rhonda player sind bei uns ständig im Einsatz und bereichern den Alltag unserer Mitarbeiter und Patienten. Für uns sind die player ein riesen Gewinn, da wir die Bettennutzungszeit durch den Einsatz von Rhonda signifikant reduzieren können. Das betrifft im Besonderen unsere ZNA.”

Bianca Klein, Laborleitung, RoMed Klinikum Rosenheim

Who we are

Founded in 2016, Spindiag is a spin-off from the renowned research institute Hahn-Schickard. From the vision of seven scientists, a young innovative medical technology start-up was formed, consisting of a highly motivated continuously growing team of more than 100 employees today. Spindiag comprises a team with valuable know-how from different fields in science, research & development, production, marketing, quality, sales, and services supported by external advisors.

We aim to arm the world with an effective tool against epidemic and pandemic infectious diseases: for this purpose, we introduced the point-of-care testing system Rhonda, quickly delivering reliable in-vitro diagnostic PCR results in well under one hour. We envision, that patients will be safer thanks to Rhonda, the new gold standard for routine infection control. Providing a safe, simple, and efficient solution to healthcare workers, to perform routine infection control.
In doing so, we follow our mission every day to improve world health by simply providing diagnostic results.

In 2020, we launched a point-of-care PCR rapid test for the detection of SARS-CoV-2. The video illustrates the pandemic situation that threatened the world, and the solution that Spindiag is offering. It showcases the complete workflow from sample collection to result.
Enjoy our video here!